# National Healthcare Corp: filings

NHC · NYSE · CIK 1047335 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nhc.md) · [Financials](/companies/nhc/financials.md) · [Filings](/companies/nhc/filings.md) · [Insiders](/companies/nhc/insiders.md)

## Reports and events: 272 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 792, 8-K 174, 5 88, 10-Q 53, SC 13G/A 33, 4/A 19, 10-K 18, DEF 14A 17, UPLOAD 14, 3 11, CORRESP 11, ARS 9, SC 13G 7, 144 5, 10-K/A 4, 5/A 4, 8-K/A 3, DEFA14A 3, S-8 3, SC 13D/A 3, SCHEDULE 13G/A 3, SCHEDULE 13G 2, 25-NSE 1, PRE 14A 1, PX14A6G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 14:39 ET | [8-K](/filings/0001437749-26-026960.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-026960 |
| 2026-08-11 | 14:38 ET | [8-K](/filings/0001437749-26-026957.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026957 |
| 2026-08-06 | 14:53 ET | [10-Q](/filings/0001437749-26-026199.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026199 |
| 2026-07-01 | 16:43 ET | [8-K](/filings/0001437749-26-022306.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-022306 |
| 2026-05-27 | 17:13 ET | [8-K](/filings/0001437749-26-018604.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-26-018604 |
| 2026-05-15 | 16:04 ET | [8-K](/filings/0001437749-26-017374.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-017374 |
| 2026-05-13 | 09:57 ET | [8-K](/filings/0001437749-26-016571.md) | 5.07 Shareholder vote results | 0001437749-26-016571 |
| 2026-05-08 | 11:28 ET | [8-K](/filings/0001437749-26-015802.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015802 |
| 2026-05-07 | 16:28 ET | [10-Q](/filings/0001437749-26-015612.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015612 |
| 2026-05-07 | 16:23 ET | [8-K](/filings/0001437749-26-015606.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-015606 |
| 2026-04-22 | 18:46 ET | [8-K](/filings/0001437749-26-012953.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012953 |
| 2026-04-02 | 16:31 ET | [DEF 14A](/filings/0001140361-26-013005.md) | Proxy statement, period 2026-05-07 | 0001140361-26-013005 |
| 2026-02-27 | 09:47 ET | [8-K](/filings/0001437749-26-006000.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-006000 |
| 2026-02-26 | 17:16 ET | [10-K](/filings/0001437749-26-005910.md) | Annual report, period 2025-12-31 | 0001437749-26-005910 |
| 2026-02-17 | 10:38 ET | [8-K](/filings/0001437749-26-004270.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-004270 |
| 2026-02-13 | 09:42 ET | [8-K](/filings/0001437749-26-004009.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-004009 |
| 2025-11-12 | 16:17 ET | [8-K](/filings/0001437749-25-034451.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-034451 |
| 2025-11-07 | 09:20 ET | [8-K](/filings/0001437749-25-033736.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-033736 |
| 2025-11-07 | 09:18 ET | [8-K](/filings/0001437749-25-033734.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033734 |
| 2025-11-06 | 16:39 ET | [10-Q](/filings/0001437749-25-033631.md) | Quarterly report, period 2025-09-30 | 0001437749-25-033631 |
| 2025-09-26 | 16:34 ET | [8-K](/filings/0001437749-25-029946.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029946 |
| 2025-09-12 | 17:20 ET | [8-K](/filings/0001437749-25-028968.md) | 8.01 Other events | 0001437749-25-028968 |
| 2025-08-08 | 10:16 ET | [8-K](/filings/0001437749-25-025579.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025579 |
| 2025-08-08 | 10:11 ET | [8-K](/filings/0001437749-25-025577.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-025577 |
| 2025-08-07 | 17:08 ET | [10-Q](/filings/0001437749-25-025500.md) | Quarterly report, period 2025-06-30 | 0001437749-25-025500 |
| 2025-05-13 | 16:11 ET | [8-K](/filings/0001437749-25-016458.md) | 5.07 Shareholder vote results | 0001437749-25-016458 |
| 2025-05-09 | 09:37 ET | [8-K](/filings/0001437749-25-015666.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-015666 |
| 2025-05-09 | 09:36 ET | [8-K](/filings/0001437749-25-015664.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-015664 |
| 2025-05-08 | 16:13 ET | [10-Q](/filings/0001437749-25-015499.md) | Quarterly report, period 2025-03-31 | 0001437749-25-015499 |
| 2025-04-08 | 16:07 ET | [8-K](/filings/0001437749-25-011399.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-25-011399 |
| 2025-03-28 | 16:36 ET | [DEF 14A](/filings/0001140361-25-011007.md) | Proxy statement, period 2025-05-08 | 0001140361-25-011007 |
| 2025-03-03 | 16:33 ET | [10-K/A](/filings/0001437749-25-005928.md) | Annual report, amended, period 2024-12-31 | 0001437749-25-005928 |
| 2025-02-28 | 15:05 ET | [10-K](/filings/0001437749-25-005690.md) | Annual report, period 2024-12-31 | 0001437749-25-005690 |
| 2025-02-27 | 17:13 ET | [8-K](/filings/0001437749-25-005510.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-005510 |
| 2025-02-18 | 09:29 ET | [8-K](/filings/0001437749-25-004137.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-004137 |
| 2024-11-14 | 17:32 ET | [8-K](/filings/0001437749-24-034983.md) | 5.02 Departure or appointment of officers or directors | 0001437749-24-034983 |
| 2024-11-12 | 09:41 ET | [8-K](/filings/0001437749-24-034376.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034376 |
| 2024-11-12 | 09:39 ET | [8-K](/filings/0001437749-24-034374.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-034374 |
| 2024-11-07 | 16:59 ET | [10-Q](/filings/0001437749-24-033970.md) | Quarterly report, period 2024-09-30 | 0001437749-24-033970 |
| 2024-08-09 | 10:37 ET | [8-K](/filings/0001437749-24-025687.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-025687 |
| 2024-08-09 | 10:37 ET | [8-K](/filings/0001437749-24-025685.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-025685 |
| 2024-08-08 | 17:07 ET | [10-Q](/filings/0001437749-24-025603.md) | Quarterly report, period 2024-06-30 | 0001437749-24-025603 |
| 2024-08-06 | 15:50 ET | [8-K](/filings/0001437749-24-024854.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-024854 |
| 2024-07-11 | 16:29 ET | [8-K](/filings/0001437749-24-022577.md) | 5.02 Departure or appointment of officers or directors | 0001437749-24-022577 |
| 2024-05-31 | 17:25 ET | [8-K](/filings/0001437749-24-018940.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-018940 |
| 2024-05-15 | 17:33 ET | [8-K](/filings/0001437749-24-016722.md) | 5.07 Shareholder vote results | 0001437749-24-016722 |
| 2024-05-10 | 10:30 ET | [8-K](/filings/0001437749-24-015875.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-015875 |
| 2024-05-10 | 10:28 ET | [8-K](/filings/0001437749-24-015872.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-015872 |
| 2024-05-09 | 17:11 ET | [10-Q](/filings/0001437749-24-015736.md) | Quarterly report, period 2024-03-31 | 0001437749-24-015736 |
| 2024-04-05 | 16:30 ET | [DEF 14A](/filings/0001140361-24-018333.md) | Proxy statement, period 2024-05-09 | 0001140361-24-018333 |

Page 1 of 6. [Older](/companies/nhc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 10:11 ET. No prices; not investment advice.